Evidence map›Paper›PMID 38826218›Full record

ArticlebioRxiv : the preprint server for biology2025

Matthew J Seasock, Md Shafiquzzaman, Maria E Ruiz-Echartea, Rupa S Kanchi, Brandon T Tran, Lukas M Simon, Matthew D Meyer, Phillip A Erice, Shivani L Lotlikar, Stephanie C Wenlock and 9 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Matthew J SeasockImmunology & Microbiology Graduate Program, Baylor College of Medicine, Houston, TX, 77030.
Md ShafiquzzamanDepartment of Medicine, Section of Immunology, Allergy & Rheumatology, Baylor College of Medicine Houston TX, 77030.
Maria E Ruiz-EcharteaDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030.
Rupa S KanchiDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030.
Brandon T TranGraduate Program of Cancer Biology and Cell Biology, Baylor College of Medicine, Houston, TX, 77030.
Lukas M SimonTherapeutic Innovation Center, Baylor College of Medicine, Houston, TX, 77030.
Matthew D MeyerShared Equipment Authority, Rice University, Houston, TX 77005.
Phillip A EriceImmunology & Microbiology Graduate Program, Baylor College of Medicine, Houston, TX, 77030.
Shivani L LotlikarDepartment of Medicine, Section of Immunology, Allergy & Rheumatology, Baylor College of Medicine Houston TX, 77030.
Stephanie C WenlockDepartment of Pathology, University of Cambridge, Cambridge, CB2 1TN, UK.
Scott A OchsnerDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030.
Anton EnrightDepartment of Pathology, University of Cambridge, Cambridge, CB2 1TN, UK.
Alex F CariseyWilliam T. Shearer Center for Immunobiology, Texas Children's Hospital, Houston, TX, 77030.
Freddy RomeroDepartment of Medicine, Section of Pulmonary and Critical Care, Baylor College of Medicine. Houston, TX, 77030.
Ivan O RosasDepartment of Medicine, Section of Pulmonary and Critical Care, Baylor College of Medicine. Houston, TX, 77030.
Katherine Y KingDepartment of Pediatrics, Division of Infectious Diseases, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, 77030.
Neil J McKennaDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030.ORCID 0000-0001-6689-0104
Cristian CoarfaDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030.ORCID 0000-0002-4183-4939
Antony RodriguezDepartment of Medicine, Section of Immunology, Allergy & Rheumatology, Baylor College of Medicine Houston TX, 77030.ORCID 0000-0002-6649-1856

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Suzanne AW Fuqua · 2007 to 2026
$73.9M
Project 5: Pyolytic conversion of PAHs in contaminated sediments into char to eliminate toxicity and enhance soil fertilityP42ES027725 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI Nagireddy Putluri · 2020 to 2026
$17.8M
Translational Research Support CoreP30ES030285 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI Cheryl L. Walker · 2019 to 2026
$14.7M
Initiative for Maximizing Student Development (IMSD) ProgramR25GM056929 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI PEREIRA, FRED A · 1998 to 2023
$12.4M
Impact of Infection and Inflammation on Primitive HematopoiesisR35HL155672 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Katherine Yudeh King · 2021 to 2026
$5.1M
The Clinical Translational Research Certificate of Added Qualification ProgramT32GM136554 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI Melissa Suter, IGNATIA B VAN DEN VEYVER · 2020 to 2026
$3.0M
Role of Let-7 as genetic modifier of Alzheimer's DiseaseR01HL140398 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B, RODRIGUEZ, ANTONY · 2018 to 2022
$2.4M
Delineating the role of let-7 microRNA on lung AT2 cell homeostasis, alveolar regeneration, and interstitial lung diseaseR01HL167814 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Antony Rodriguez · 2023 to 2026
$2.1M
Baylor College of Medicine Initiative for Maximizing Student DevelopmentT32GM152777 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI PANGAS, STEPHANIE A., PEREIRA, FRED A · 2024 to 2024
$547k
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430k
Epigenetic modification of hematopoietic stem and progenitor cells in inflammation-induced differentiationF31HL164287 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI TRAN, BRANDON T · 2022 to 2024
$143k
NCI NIH HHS P30 CA125123NCRR NIH HHS S10 RR024574NHLBI NIH HHS F31 HL164287NHLBI NIH HHS R01 HL140398NHLBI NIH HHS R01 HL167814NHLBI NIH HHS R35 HL155672NIEHS NIH HHS P30 ES030285NIEHS NIH HHS P42 ES027725NIGMS NIH HHS R25 GM056929NIGMS NIH HHS T32 GM136554NIGMS NIH HHS T32 GM152777
6 · The paper itself

Abstract

Analysis of lung alveolar type 2 (AT2) progenitor stem cells has highlighted fundamental mechanisms that direct their differentiation into alveolar type 1 cells (AT1s) in lung repair and disease. However, microRNA (miRNA) mediated post-transcriptional mechanisms which govern this nexus remain understudied. We show here that the

Identifiers

PMID38826218
PMCPMC11142151

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.